Skip to content
10-Q

Quarterly Report

Kiniksa Pharmaceuticals International, plc KNSA

0001558370-25-009738

← back to feed
Filed
Jul 29, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 77.94M sh
Shares Diluted Q2 2025 · Jun 30, 2025 76.98M sh
Shares Diluted Q2 2025 · Jun 30, 2024 71M sh
Shares Diluted Q2 2025 · Jun 30, 2024 70.82M sh
Capex Q2 2025 · Jun 30, 2025 $264K
Capex Q2 2025 · Jun 30, 2024 $84K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $50.41M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $9.16M
Short Term Investments Q2 2025 · Jun 30, 2025 $115.75M
Short Term Investments Q2 2025 · Dec 31, 2024 $60.05M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $192.04M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $183.58M
Stockholders Equity Q2 2025 · Jun 30, 2025 $495.01M
Stockholders Equity Q2 2025 · Mar 31, 2025 $457.49M
Stockholders Equity Q2 2025 · Dec 31, 2024 $438.44M
Stockholders Equity Q2 2025 · Jun 30, 2024 $435.1M
Stockholders Equity Q2 2025 · Mar 31, 2024 $431.9M
Stockholders Equity Q2 2025 · Dec 31, 2023 $438.84M
Current Liabilities Q2 2025 · Jun 30, 2025 $117.83M
Current Liabilities Q2 2025 · Dec 31, 2024 $100.62M
Total Liabilities Q2 2025 · Jun 30, 2025 $166.14M
Total Liabilities Q2 2025 · Dec 31, 2024 $142.12M
Current Assets Q2 2025 · Jun 30, 2025 $420.31M
Current Assets Q2 2025 · Dec 31, 2024 $331.8M
Total Assets Q2 2025 · Jun 30, 2025 $661.15M
Total Assets Q2 2025 · Dec 31, 2024 $580.55M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.23
Eps Diluted Q2 2025 · Jun 30, 2025 $0.34
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.06
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.31
Eps Basic Q2 2025 · Jun 30, 2025 $0.24
Eps Basic Q2 2025 · Jun 30, 2025 $0.36
Eps Basic Q2 2025 · Jun 30, 2024 −$0.06
Eps Basic Q2 2025 · Jun 30, 2024 −$0.31
Sga Expense Q2 2025 · Jun 30, 2025 $46.86M
Sga Expense Q2 2025 · Jun 30, 2025 $90.39M
Sga Expense Q2 2025 · Jun 30, 2024 $42.4M
Sga Expense Q2 2025 · Jun 30, 2024 $81.08M
Rd Expense Q2 2025 · Jun 30, 2025 $18.75M
Rd Expense Q2 2025 · Jun 30, 2025 $38.08M
Rd Expense Q2 2025 · Jun 30, 2024 $24.02M
Rd Expense Q2 2025 · Jun 30, 2024 $50.35M
Net Income Q2 2025 · Jun 30, 2025 $17.83M
Net Income Q2 2025 · Jun 30, 2025 $26.37M
Net Income Q2 2025 · Mar 31, 2025 $8.54M
Net Income Q2 2025 · Jun 30, 2024 −$3.91M
Net Income Q2 2025 · Jun 30, 2024 −$21.61M
Net Income Q2 2025 · Mar 31, 2024 −$17.7M
Operating Income Q2 2025 · Jun 30, 2025 $20.16M
Operating Income Q2 2025 · Jun 30, 2025 $33.43M
Operating Income Q2 2025 · Jun 30, 2024 −$117K
Operating Income Q2 2025 · Jun 30, 2024 −$16.66M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $18.6M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $36.47M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $12.32M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $22.91M
Revenue Q2 2025 · Jun 30, 2025 $156.8M
Revenue Q2 2025 · Jun 30, 2025 $294.58M
Revenue Q2 2025 · Jun 30, 2024 $108.63M
Revenue Q2 2025 · Jun 30, 2024 $188.49M